Last updated on May 2017

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)


Brief description of study

Collect blood samples and associated clinical data prior to, during, and post radiation treatment.

Detailed Study Description

In order to further refine and independently validate the performance of DxTerity's test developed during the previous pilot study, the study will collect pre-, during, and post-irradiation blood samples and associated clinical and self-reported information from up to five hundred (500) subjects for analysis. Patients with a diagnosis of primary gastrointestinal (GI), genitourinary (GU), or gynecological (GYN) cancer requiring radiation treatment to the primary disease site will be included in the study. Combining chemotherapy is allowed. Blood samples for this study will be collected from cancer patients scheduled to undergo radiation therapy prior to, during, and after treatment. Approximately 150μL of blood per time point will be obtained via fingerstick remotely, from the participant's home; participation in this study will not affect any aspect of patient treatment. Samples will be collected using DxTerity's proprietary DxCollect® MCD Fingerstick Kit (MCD).

Clinical Study Identifier: NCT03133286

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Robert Terbrueggen, PhD

DxTerity Diagnostics
Compton, CA United States
  Connect »